Cutaneous leishmaniasis. Cutaneous leishmaniasis
Conditions
Interventions
Intervention 1: Intervention group: Topical ointment of Brazambel 10%, (made by Isfahan University of Medical Sciences), School of Pharmacy, once a day, with intralesional injection of Glucantime twic
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to No maximum
Inclusion criteria
Inclusion criteria: The incidence of sores in less than 5 numbers, confirmed by microscopic testing (observation of amastigots) or cultivation of discharge (presence of moving promastigots) Sideration (diameter) wound less than 5 centimeters
Exclusion criteria
Exclusion criteria: Mucosal involvement (mucous leishmanase) Systemic conflict (visceral leishmanase) Pregnancy Lactation Disease diffused Receiving an effective drug on Leishmania during recent 8 weeks (antifungal Azithromycin, allopurinol, aminoglycoside, amphotericine b, anti-compound) Skin disease associated with The existence of the lesion in ear, face or near the mucous district The secondary bacterial infection in the wound
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percent of decrease in lesion. Timepoint: Baseline, 7 and 14 Days after Initiation of Intervention. Method of measurement: Ruler. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome variable is the time required for complete recovery. Timepoint: Baseline, 7 and 14 Days after Initiation of Intervention. Method of measurement: Observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRasool Soltani
Esfahan University of Medical Sciences
Outcome results
None listed